Cargando…

Putative Biomarkers and Targets of Estrogen Receptor Negative Human Breast Cancer

Breast cancer is a progressive and potentially fatal disease that affects women of all ages. Like all progressive diseases, early and reliable diagnosis is the key for successful treatment and annihilation. Biomarkers serve as indicators of pathological, physiological, or pharmacological processes....

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahab, Ziad J., Man, Yan-Gao, Byers, Stephen W., Sang, Qing-Xiang A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155366/ https://www.ncbi.nlm.nih.gov/pubmed/21845093 http://dx.doi.org/10.3390/ijms12074504

Ejemplares similares

Novel Stromal Biomarkers in Human Breast Cancer Tissues Provide Evidence for the More Malignant Phenotype of Estrogen Receptor-Negative Tumors
por: Khamis, Zahraa I., et al.
Publicado: (2011)

Methodology and Applications of Disease Biomarker Identification in Human Serum
por: Sahab, Ziad J., et al.
Publicado: (2007)

The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
por: Narbe, Ulrik, et al.
Publicado: (2019)

Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer
por: Vallega, Karin A., et al.
Publicado: (2016)

Active Roles of Tumor Stroma in Breast Cancer Metastasis
por: Khamis, Zahraa I., et al.
Publicado: (2012)

Identification of Potential Glycoprotein Biomarkers in Estrogen Receptor Positive (ER+) and Negative (ER-) Human Breast Cancer Tissues by LC-LTQ/FT-ICR Mass Spectrometry
por: Semaan, Suzan M., et al.
Publicado: (2012)

Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing
por: Wolfson, Benjamin, et al.
Publicado: (2021)

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004)

The prevalence of estrogen receptor-negative breast cancer in Ethiopia
por: Kantelhardt, Eva Johanna, et al.
Publicado: (2014)

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
por: Austin, David, et al.
Publicado: (2018)

Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers
por: Zhou, Xianxiao, et al.
Publicado: (2013)

Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer
por: Chan, Melissa, et al.
Publicado: (2015)

Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer
por: Xu, Junnan, et al.
Publicado: (2018)

Targeted Biomarker Profiling of Matched Primary and Metastatic Estrogen Receptor Positive Breast Cancers
por: Schleifman, Erica B., et al.
Publicado: (2014)

Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells
por: Chen, Xingxing, et al.
Publicado: (2017)

Triple-negative breast cancer that progressed as estrogen receptor-positive skin metastases
por: Lee, Sang Min, et al.
Publicado: (2015)

Quantification of angiogenesis in estrogen receptor-positive and negative breast carcinoma
por: Parentes-Vieira, JB, et al.
Publicado: (2007)

Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer
por: Litzenburger, Beate C., et al.
Publicado: (2014)

PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer
por: Glazer, Robert I., et al.
Publicado: (2017)

Biomarker Genes for Detecting Estrogenic Activity of Endocrine Disruptors via Estrogen Receptors
por: Jung, Eui-Man, et al.
Publicado: (2012)

Targeted Next-Generation Sequencing Identifies Actionable Targets in Estrogen Receptor Positive and Estrogen Receptor Negative Endometriod Endometrial Cancer
por: Suhaimi, Siti Syazani, et al.
Publicado: (2018)

Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer
por: Mehmeti, Meliha, et al.
Publicado: (2015)

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival
por: Takano, Elena A., et al.
Publicado: (2023)

Promoter Hypermethylation of Estrogen Receptor Alpha Gene Is Correlated to Estrogen Receptor Negativity in Iranian Patients with Sporadic Breast Cancer
por: Izadi, Pantea, et al.
Publicado: (2012)

Coffee consumption modifies risk of estrogen-receptor negative breast cancer
por: Li, Jingmei, et al.
Publicado: (2011)

Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
por: Kim, Ryung S., et al.
Publicado: (2012)

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020)

Role of Estrogen Receptor-Positive/Negative Ratios in Regulating Breast Cancer
por: Li, Yanchu, et al.
Publicado: (2022)

Integrated multi‐omics profiling of high‐grade estrogen receptor‐positive, HER2‐negative breast cancer
por: Wang, Kang, et al.
Publicado: (2021)

Estrogen Receptor Beta: The Promising Biomarker and Potential Target in Metastases
por: Božović, Ana, et al.
Publicado: (2021)

NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells
por: Quagliariello, Vincenzo, et al.
Publicado: (2020)

Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
por: Hefti, Marco M, et al.
Publicado: (2013)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Arsenic Induces Functional Re-Expression of Estrogen Receptor α by Demethylation of DNA in Estrogen Receptor-Negative Human Breast Cancer
por: Du, Juan, et al.
Publicado: (2012)

Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer
por: Fan, Ying, et al.
Publicado: (2015)

PGRMC1: a new biomarker for the estrogen receptor in breast cancer
por: Craven, Rolf J
Publicado: (2008)

Tumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26
por: Sahab, Ziad J., et al.
Publicado: (2010)

A genome-wide association scan on estrogen receptor-negative breast cancer
por: Li, Jingmei, et al.
Publicado: (2010)

Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer
por: Lipsey, Crystal C., et al.
Publicado: (2020)

CDDO-Me Alters the Tumor Microenvironment in Estrogen Receptor Negative Breast Cancer
por: Ball, Michael S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bv223d5b94t4sad2sralqqc6tn